NCT02287857 - Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis B | Biotech Hunter

Enrollment

360

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions

Chronic Hepatitis B

Interventions

DRUG

Domestic Tenofovir Disoproxil Fumarate Tablets

1 Domestic Tenofovir Disoproxil Fumarate Tablets and 1 blank Tenofovir Disoproxil Fumarate Tablets of Gilead

DRUG

Tenofovir Disoproxil Fumarate Tablets of Gilead

1 blank Domestic Tenofovir Disoproxil Fumarate Tablets and 1Tenofovir Disoproxil Fumarate Tablets of Gilead

Trial Locations (15)

100015

RECRUITING

Beijing Ditan Hospital Capital Medical University, Beijing

100034

RECRUITING

Peking University First Hospital, Beijing

100044

RECRUITING

Peking University People's Hospital, Beijing

100069

RECRUITING

Beijing You An Hospital, Capital Medical University, Beijing

200025

RECRUITING

Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai

200040

RECRUITING

Huashan Hospital, Fudan University, Shanghai

201508

RECRUITING

Shanghai Public Health Clinical Center, Shanghai

210003

RECRUITING

The Second Hospital of Nanjing, Nanjing

400039

RECRUITING

First Affiliated Hospital, Third Military Medical University, Chongqing

450003

RECRUITING

Henan Provincial People's Hospital, Zhengzhou

450052

RECRUITING

First Affiliated Hospital of Zhengzhou University, Zhengzhou

510630

RECRUITING

Third Affiliated Hospital of Sun Yat-sen, Guangzhou

610041

RECRUITING

West China Hospital of Sichuan University, Chengdou

Unknown

RECRUITING

First Affiliated Hospital of Nanjing Medical University, Nanjing

RECRUITING

First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou